CADTH Canadian Drug Expert Committee recommendation. indication: Type 1 Gaucher disease. Eliglustat (Cerdelga -- Sanofi Genzyme) :
Saved in:
Online Access: |
http://www.ncbi.nlm.nih.gov/books/NBK534706/ Full text |
---|---|
Corporate Author: | |
Format: | Electronic eBook |
Language: | English |
Published: |
Ottawa (ON) :
Canadian Agency for Drugs and Technologies in Health,
2017
|
Edition: | Version 1.0. |
Series: | Common drug review clinical review report.
|
Subjects: |